Facebook
Twitter
Telegram
Report an ErrorPulse Biosciences Financial Ratios 2011-2024 | PLSE
Annual Financial Ratios Pulse Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-9.9 | -1.6 | -5.3 | -15.9 | -6.4 | -5.9 | -11.8 | -7.2 | - | - | - | - | - |
P/S |
- | 136.7 | 239.8 | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.9 | -1.7 | -2.3 | -2.1 | -2.3 | -2.2 | -1.7 | -0.9 | -0.4 | - | - | - | - |
EV (Enterprise Value) |
389 M | 115 M | 330 M | 800 M | 307 M | 174 M | 303 M | 67.5 M | -2.95 M | -5.19 M | - | - | - |
EBITDA per Share |
-0.9 | -1.69 | -2.24 | -2.13 | -2.28 | -2.18 | -1.7 | -0.81 | - | - | - | - | - |
EV/EBITDA |
-5.2 | -15.9 | -6.3 | -4.5 | -11.9 | -7.5 | - | - | - | - | - | ||
PEG |
0.73 | -1.25 | -0.19 | 2.52 | 2.36 | 0.22 | 0.12 | 0.05 | - | - | - | - | - |
P/B |
9.4 | -42.6 | 9.5 | 34.7 | 9.8 | 3.3 | 6.6 | 2.7 | - | - | - | - | - |
P/CF |
-12.7 | -2.0 | -6.3 | -22.4 | -8.7 | -9.1 | -22.2 | -8.5 | - | - | - | - | - |
ROE % |
-95.15 | 2602.54 | -178.37 | -217.75 | -152.82 | -56.60 | -55.59 | -37.62 | - | - | - | - | - |
ROA % |
-71.36 | -75.12 | -117.35 | -120.73 | -112.06 | -53.15 | -51.32 | -36.17 | - | - | - | - | - |
ROCE % |
-98.23 | 2582.61 | -176.56 | -218.24 | -128.03 | -56.21 | -54.22 | -37.89 | - | - | - | - | - |
Current Ratio |
4.0 | 1.0 | 2.9 | 2.2 | 5.9 | 19.4 | 17.4 | 16.4 | - | - | - | - | - |
DSO |
- | 15.9 | 7.9 | - | - | - | - | - | - | - | - | - | - |
DIO |
- | 89.0 | 540.1 | - | - | - | - | - | - | - | - | - | - |
DPO |
- | 68.4 | 428.5 | 1343.2 | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 104.9 | 547.9 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 36.5 | 119.4 | -1343.2 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Pulse Biosciences
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.18 | - | -0.19 | -0.22 | -0.26 | - | -0.49 | -0.44 | -0.58 | - | -0.48 | -0.58 | -0.71 | - | -0.51 | -0.53 | -0.57 | -0.66 | -0.57 | -0.55 | -0.49 | -0.51 | -0.64 | -0.54 | -0.51 | -0.53 | -0.52 | -0.43 | -0.23 | -0.21 | -0.21 | -0.23 | -0.22 | -0.13 | -0.1 | -0.08 | -0.06 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.19 | - | -0.2 | -0.23 | -0.25 | - | -0.48 | -0.44 | -0.58 | - | -0.48 | -0.56 | -0.71 | - | -0.51 | - | - | -0.65 | -0.56 | -0.54 | -0.48 | -0.5 | -0.62 | -0.53 | -0.51 | -0.52 | -0.51 | -0.43 | -0.23 | -0.2 | -0.21 | -0.23 | -0.22 | -0.18 | -0.16 | -0.13 | -0.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-84.84 | 55.23 | -236.24 | -507.44 | -550.84 | -434.30 | -464.44 | -203.11 | -168.98 | -147.17 | -203.49 | -229.68 | -253.54 | -157.69 | -202.55 | -184.43 | -171.88 | -152.82 | -121.45 | -99.46 | -76.32 | -56.60 | -62.02 | -62.08 | -61.70 | -55.59 | -47.77 | -42.43 | -37.92 | -37.62 | -33.96 | -28.52 | -23.98 | -20.57 | -13.13 | -7.63 | -3.25 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-65.92 | -43.24 | -63.84 | -68.41 | -89.63 | -98.77 | -120.04 | -120.71 | -105.37 | -63.55 | -94.78 | -104.74 | -113.04 | -87.43 | -120.32 | -117.11 | -116.77 | -112.06 | -91.84 | -79.05 | -64.92 | -53.15 | -57.94 | -57.74 | -57.17 | -51.32 | -44.52 | -40.01 | -36.19 | -36.17 | -32.60 | -27.32 | -22.92 | -19.62 | -12.52 | -7.28 | -3.10 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-89.31 | 51.15 | -240.09 | -509.76 | -552.70 | -434.15 | -464.27 | -203.15 | -168.08 | -145.72 | -202.09 | -228.34 | -203.56 | -101.23 | -146.08 | -127.93 | -120.03 | -152.82 | -121.45 | -99.46 | -76.32 | -56.60 | -62.02 | -62.08 | -61.70 | -55.59 | -47.77 | -42.43 | -37.92 | -37.62 | -37.75 | -35.85 | -33.92 | -32.70 | -21.46 | -12.43 | -5.44 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
3.8 | 4.0 | 4.8 | 5.2 | 0.9 | 1.0 | 1.1 | 2.4 | 2.1 | 2.9 | 3.4 | 3.9 | 1.3 | 2.2 | 2.2 | 2.2 | 2.2 | 3.8 | 3.8 | 3.8 | 3.8 | 16.4 | 16.4 | 16.4 | 16.4 | 13.0 | 13.0 | 13.0 | 13.0 | 25.9 | 25.9 | 25.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | 5.0 | 8.4 | - | 5.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | 46.8 | 521.4 | 668.1 | - | 437.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | 21.6 | 184.5 | 320.7 | - | 347.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | 46.8 | 526.4 | 676.5 | - | 443.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | 25.3 | 341.9 | 355.8 | - | 96.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency